UK markets close in 4 hours 36 minutes
  • FTSE 100

    7,261.25
    -16.37 (-0.22%)
     
  • FTSE 250

    23,168.03
    +6.76 (+0.03%)
     
  • AIM

    1,230.85
    -2.47 (-0.20%)
     
  • GBP/EUR

    1.1829
    -0.0041 (-0.35%)
     
  • GBP/USD

    1.3720
    -0.0044 (-0.32%)
     
  • BTC-GBP

    43,105.39
    -3,016.14 (-6.54%)
     
  • CMC Crypto 200

    1,420.03
    -85.12 (-5.66%)
     
  • S&P 500

    4,574.79
    +8.31 (+0.18%)
     
  • DOW

    35,756.88
    +15.73 (+0.04%)
     
  • CRUDE OIL

    83.50
    -1.15 (-1.36%)
     
  • GOLD FUTURES

    1,790.90
    -2.50 (-0.14%)
     
  • NIKKEI 225

    29,098.24
    -7.77 (-0.03%)
     
  • HANG SENG

    25,628.74
    -409.53 (-1.57%)
     
  • DAX

    15,719.77
    -37.29 (-0.24%)
     
  • CAC 40

    6,748.05
    -18.46 (-0.27%)
     

French company Carmat announces first implant of its artificial heart in a woman

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
Artificial heart produced by French manufacturer Carmat
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

PARIS (Reuters) - French artificial heartmaker Carmat announced on Tuesday that it had carried out the first implant of its Aeson artificial heart in a woman.

The company said the procedure had been performed at the UofL Health - Jewish Hospital by University of Louisville physicians in the United States.

"This third implant in the U.S. was a landmark event not only because it allowed us to finalize the enrollment of the first cohort of patients of the EFS (early feasibility study), but very importantly because it is the first time ever that our device has helped a woman suffering from heart failure," Carmat CEO Stephane Piat said in a statement.

(Reporting by Matthieu Protard; Editing by Sudip Kar-Gupta)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting